The short answer
Avoid excessive caffeine while taking isocarboxazid. The current Marplan label gives this instruction, and a case with another MAO inhibitor links high caffeinated-coffee intake to severe hypertension. The available sources do not establish serotonin syndrome or QT prolongation from this exact pair.
What this answer covers
Caffeine in any oral source, including drinks, foods and supplements, with oral isocarboxazid. The label does not define an exact safe daily amount.
- Supplement or preparation
- Caffeine
- Medication ingredient
- isocarboxazid
What the label actually says
Marplan labeling tells patients to avoid excessive caffeine in any form. It does not set a milligram cutoff, so a product label and the total from coffee, tea, energy drinks, chocolate and supplements all matter.
The supported concern is blood pressure
A published case report identifies severe hypertension related to caffeinated coffee and tranylcypromine. That is indirect evidence because the drug was not isocarboxazid, but it is consistent with the current Marplan caution.
What the evidence does not establish
The sources inspected for this pair do not show that caffeine with isocarboxazid causes serotonin syndrome or QT prolongation. The evidence supports a caffeine limit because of blood-pressure concern, while those other outcomes remain unproven for this pair.
Use a total-intake plan
Ask the prescriber or pharmacist what limit fits the individual patient and count all caffeine sources. A few hours of spacing has not been shown to remove the concern. Seek urgent care for a sudden severe headache, chest pain, marked palpitations, neck stiffness, sweating, nausea or vomiting.
Evidence and practical considerations
Side effects & toxicity
Current Marplan labeling says excessive caffeine should be avoided; indirect human evidence with tranylcypromine reports severe hypertension during high caffeinated-coffee intake.
- Exact scope
- Oral caffeine from supplements, drinks or foods; risk is framed around excessive or high intake. with Oral isocarboxazid tablets.
- Medication form and route
- oral
What remains uncertain
- No controlled isocarboxazid-caffeine study or validated safe threshold was identified. The case used tranylcypromine.
Factors that may matter: Total caffeine from all sources matters.; Baseline cardiovascular disease, hypertension or headache history increases concern under the Marplan label..
Read the supporting source summaries
Source 1: Current U.S. prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral Marplan tablets for depression.
The label says excessive caffeine should be avoided. It separately states that tyrosine and tryptophan with Marplan may precipitate hypertension, headache, and related symptoms, and describes a neurologic and behavioral syndrome reported with MAO inhibitors plus tryptophan. It also warns that serious reactions may occur when MAO inhibitors are given with serotonergic drugs, with examples that do not include Hypericum perforatum.
How this applies: Primary authority for current oral isocarboxazid precautions. Applicability is direct only where the exact supplement is named.
The label gives no safe caffeine threshold and no exact-pair event rates. It does not name Hypericum perforatum. Its tryptophan syndrome summary includes MAO-inhibitor class reports rather than an identified isocarboxazid case series.
Source 2: Human case report
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One 56-year-old man with previously treated hypertension and major depressive disorder.
Severe hypertension improved after caffeinated coffee was withdrawn while tranylcypromine continued; normal pressure persisted with decaffeinated coffee.
How this applies: Supports concern about high caffeine intake as an MAOI class signal, while the current Marplan label supplies the exact-drug instruction.
Single uncontrolled case; tranylcypromine rather than isocarboxazid, high tranylcypromine dose, prior hypertension, smoking and other exposures limit generalization. Coffee is not purified caffeine, and no safe caffeine threshold was established.
Research assessment: · Open full citations ↗
Side effects & toxicity
The inspected evidence does not establish serotonin syndrome or QT prolongation from caffeine plus isocarboxazid.
- Exact scope
- Oral caffeine. with Oral isocarboxazid tablets.
- Medication form and route
- oral
What remains uncertain
- A targeted search cannot prove that no event has ever occurred.
Factors that may matter: Blood-pressure effects are assessed separately..
Read the supporting source summaries
Source 1: Current U.S. prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral Marplan tablets for depression.
The label says excessive caffeine should be avoided. It separately states that tyrosine and tryptophan with Marplan may precipitate hypertension, headache, and related symptoms, and describes a neurologic and behavioral syndrome reported with MAO inhibitors plus tryptophan. It also warns that serious reactions may occur when MAO inhibitors are given with serotonergic drugs, with examples that do not include Hypericum perforatum.
How this applies: Primary authority for current oral isocarboxazid precautions. Applicability is direct only where the exact supplement is named.
The label gives no safe caffeine threshold and no exact-pair event rates. It does not name Hypericum perforatum. Its tryptophan syndrome summary includes MAO-inhibitor class reports rather than an identified isocarboxazid case series.
Source 2: Human case report
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One 56-year-old man with previously treated hypertension and major depressive disorder.
Severe hypertension improved after caffeinated coffee was withdrawn while tranylcypromine continued; normal pressure persisted with decaffeinated coffee.
How this applies: Supports concern about high caffeine intake as an MAOI class signal, while the current Marplan label supplies the exact-drug instruction.
Single uncontrolled case; tranylcypromine rather than isocarboxazid, high tranylcypromine dose, prior hypertension, smoking and other exposures limit generalization. Coffee is not purified caffeine, and no safe caffeine threshold was established.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial targeted source-checked draft. Current claims were adjudicated against the current Marplan label and inspected clinical literature. Clinical review has not occurred. | |
| Research summary published |
Article revision: 4376165e8a642659
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.